Personal information

No personal information available

Activities

Employment (2)

University of Cambridge: Cambridge, Cambridgeshire, GB

2015-01-07 to present | Senior Post-Doc (CRUK Cambridge Institute)
Employment
Source: Self-asserted source
Christopher Smith

Cardiff University: Cardiff, South Glamorgan, GB

2011 to 2015-12 | Post-doctoral researcher (Division of Cancer Genetics)
Employment
Source: Self-asserted source
Christopher Smith

Education and qualifications (2)

Cardiff University: Cardiff, South Glamorgan, GB

2007 to 2011 | PhD
Qualification
Source: Self-asserted source
Christopher Smith

Cardiff University: Cardiff, South Glamorgan, GB

2004 to 2007 | Biochemistry with Medical Biochemistry
Education
Source: Self-asserted source
Christopher Smith

Works (9)

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)

British Journal of Cancer
2022-10-05 | Journal article
Contributors: Grant D. Stewart; Sarah J. Welsh; Stephan Ursprung; Ferdia A. Gallagher; James O. Jones; Jacqui Shields; Christopher G. Smith; Thomas J. Mitchell; Anne Y. Warren; Axel Bex et al.
Source: check_circle
Crossref

Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework

Science Advances
2022-09-30 | Journal article
Contributors: Sabrina H. Rossi; Izzy Newsham; Sara Pita; Kevin Brennan; Gahee Park; Christopher G. Smith; Radoslaw P. Lach; Thomas Mitchell; Junfan Huang; Anne Babbage et al.
Source: check_circle
Crossref

Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA

Genome Research
2022-02 | Journal article
Contributors: Irena Hudecova; Christopher G. Smith; Robert Hänsel-Hertsch; Chandra S. Chilamakuri; James A. Morris; Aadhitthya Vijayaraghavan; Katrin Heider; Dineika Chandrananda; Wendy N. Cooper; Davina Gale et al.
Source: check_circle
Crossref

Refined characterization of circulating tumor DNA through biological feature integration

2021-08-12 | Other
Contributors: Havell Markus; Dineika Chandrananda; Elizabeth Moore; Florent Mouliere; James Morris; James Brenton; Christopher G. Smith; Nitzan Rosenfeld
Source: check_circle
Crossref

Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients

EMBO Molecular Medicine
2021-08-09 | Journal article
Contributors: Florent Mouliere; Christopher G Smith; Katrin Heider; Jing Su; Ymke van der Pol; Mareike Thompson; James Morris; Jonathan C M Wan; Dineika Chandrananda; James Hadfield et al.
Source: check_circle
Crossref

Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors

Genome Medicine
2020-12 | Journal article
Contributors: Christopher G. Smith; Tina Moser; Florent Mouliere; Johanna Field-Rayner; Matthew Eldridge; Anja L. Riediger; Dineika Chandrananda; Katrin Heider; Jonathan C. M. Wan; Anne Y. Warren et al.
Source: check_circle
Crossref

Comprehensive characterisation of cell-free tumour DNA in plasma and urine of patients with renal tumours

2019-09-11 | Other
Contributors: Christopher G Smith; Tina Moser; Johanna Burge; Matthew Eldridge; Anja L Riediger; Florent Mouliere; Dineika Chandrananda; Katrin Heider; Jonathan CM Wan; Anne Y Warren et al.
Source: check_circle
Crossref

Integrated clonal analysis reveals circulating tumor DNA in urine and plasma of glioma patients

2019-09-11 | Other
Contributors: Florent Mouliere; Katrin Heider; Christopher G. Smith; Jing Su; Mareike Thompson; James Morris; Jonathan C.M. Wan; Dineika Chandrananda; James Hadfield; Marta Grezlak et al.
Source: check_circle
Crossref

Detection of ctDNA from dried blood spots after DNA size selection

2019-09-05 | Other
Contributors: Katrin Heider; Jonathan C. M. Wan; James Hall; Samantha Boyle; Irena Hudecova; Davina Gale; Wendy N. Cooper; Pippa G. Corrie; James D. Brenton; Christopher G. Smith et al.
Source: check_circle
Crossref

Peer review (3 reviews for 3 publications/grants)

Review activity for British journal of cancer. (1)
Review activity for Genome medicine. (1)
Review activity for Nature biotechnology. (1)